Trenches, Silos And Circular Debates: European Health Forum Calls For Collaboration On IP And Medicines Access
Executive Summary
A session on intellectual property and its effects on access to new medicines was the subject of heated debate at the recent European Health Forum Gastein conference, with proponents of strong IP protections locking horns with health activists over issues such as the link between IP and high prices.
You may also be interested in...
Use Of Compulsory Licensing ‘More Frequent Than Commonly Assumed’
A report in the WHO Bulletin says that the use of the TRIPS flexibilities has been much greater than is commonly assumed, dispelling the belief that such use has been sporadic and limited.
Use Of Compulsory Licensing ‘More Frequent Than Commonly Assumed’
A report in the WHO Bulletin says that the use of the TRIPS flexibilities has been much greater than is commonly assumed, dispelling the belief that such use has been sporadic and limited.
The BeNeLuxA Medicines Access Coalition: Resetting The Balance of Power in Europe?
The BeNeLuxA coalition shows that “resetting the balance of power” is possible to give governments more clout in pricing negotiations, says the European Public Health Alliance.